This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Telix Pharmaceuticals is expanding its theranostic pipeline with newly acquired assets targeting fibroblast activation protein (FAP) in nuclear medicine. Telix said these new therapeutic assets are differentiated by a structure that drives extended tumor retention while minimizing off-target uptake.
a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for cancer detection and treatment, announced an exclusive licensing agreement for RefleXion to develop and commercialize a specific 3BP molecule to direct its SCINTIX biology-guided radiotherapy.
Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.
GE HealthCare (GEHC) reported a 1% growth in existing operation revenues and an increase in profitability in its second quarter of 2024, citing solid performance in its PharmaceuticalDiagnostics segment. For the period (end-September 30), GEHC had total revenues of $4.86 billion, flat compared with $4.82 last year to 16.3%
Campione also joins the Blue Earth Diagnostics Ltd. Board of Directors and will serve as Vice Chair of the Blue Earth Diagnostics Inc. Board of Directors and will serve as Vice Chair of the Blue Earth Diagnostics Inc. Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., Board of Directors.
Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, and PSI CRO, a global contract research organization, plan to conduct a trial using Clarity's phase III diagnostic trial of Clarify for prostate cancer patients.
As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. At the time, their cancer center served a significant cancer population in the region and maintained robust and ever-expanding PET diagnostics.
Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. In the U.S., FES PET, like FDG PET, is now included in the NCCN Guidelines. The NCCN is a not-for-profit alliance of 33 leading U.S.
-based company, to develop, manufacture and commercialize SOFIE’s Gallium-68 and Fluorine-18 labelled diagnostics targeting fibroblast activation protein (FAP). SOFIE will continue its clinical development and commercialization program with [18F]FAPI-74 in the U.S. Financial terms were not disclosed. Sherly Mosessian , Ph.D,
milla1cf Fri, 06/21/2024 - 20:24 June 21, 2024 — GE HealthCare , a leading global medical technology, pharmaceuticaldiagnostics, and digital solutions innovator, and MediView XR Inc., Proceduralists must refer to standard of care imaging and prioritize clinical experience and/or judgment when using the OmnifyXR system.
The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use.
The research will produce technical feedback to assist GEHC in assessing the system’s reconstruction methods, image presentation workflow, and clinical benefits for specific pathologies and disease types. MRI GEHC unveiled Signa Champion, a 1.5-tesla,
Clinical trials for MASH drugs rely on various imaging modalities to provide quantitative and qualitative data regarding liver health, fat content, fibrosis, and inflammation. In obesity management, for instance, imaging techniques can offer precise measurements of visceral fat, enabling tailored treatment plans and monitoring progress.
Medical isotopes are essential for a wide range of diagnostic and therapeutic procedures, including cancer treatments and advanced imaging techniques. An active DMF enables clinical investigators or pharmaceutical companies to reference the filing in their regulatory submissions. a subsidiary of BWX Technologies, Inc.
Not for use in diagnostic procedures. “We The company noted it recently released findings from a study conducted with Quest Diagnostics, a leading provider of diagnostic information services, on the impact of its AI-enabled workflows. Concentriq AP is for research use only.
The project is the second funded and supported by NEURii, a global collaboration between the pharmaceutical company Eisai, Gates Ventures, the University of Edinburgh, the medical research charity LifeArc and the national health data science institute Health Data Research UK.
The digital pathology solution was cleared for the purpose of primary diagnosis, reported the company, adding that it is cleared (K230839) for clinical use with the Hamamatsu NanoZoomer S360MD Slide scanner in the United States. Up to 70% of clinical decisions depend on pathology 1. Reference: 1. NHS England (2017).
The recommendation was issued by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA), the primary body in the European Union responsible for regulating pharmaceuticals. The PRAC noted that no clinical diseases or even symptoms have been reported in connection with gadolinium deposition.
RTX-1363S has the potential to transform the way we detect and monitor various epithelial-derived cancers." "We are delighted by our collaboration with Ratio Therapeutics in advancing the clinical development of RTX-1363S as a FAP-targeted diagnostic to the clinic," stated Etienne Montagut , Lantheus' Chief Business Officer. "By
a clinical-stage biotech developing groundbreaking secretome therapeutics for age and disease-related immune dysfunction, has announced a partnership with Springbok Analytics , a life sciences muscle analytics company. christine.book Thu, 07/25/2024 - 12:44 July 25, 2024 — Immunis, Inc. ,
Big data has become a pillar in modern pharmaceutical practices. Pharmaceutical companies have also leveraged big data in third-party collaborations, resulting in more efficient product deployment and customer experiences. Industry experts predict the pharmaceutical analytical testing market could total an estimated USD 8.98
produced, non-uranium based Mo-99 for use in diagnostic imaging. RadioGenix Systems have generated almost two million doses of Tc-99m for patients’ diagnostic imaging studies to date, with utilization continuing to steadily increase. Our track record of success includes our program to supply U.S.-produced,
NeuroShield is currently in clinical use in over 220+ sites across the world. In-Med is supported by seed funding from Sriram Natarajan, Founder & CEO of Molbio Diagnostics. Role of Volumetric Analysis in Correlation of Gender and Atrophy in Dementia in Clinical Practice. References: [i] JOSHI, J. Kulkarni, A.
christine.book Thu, 03/21/2024 - 10:34 March 21, 2024 — Diagnostic imaging provider US Radiology Specialists has announced that Lee Cooper will become its new Chief Executive Officer (CEO), and that current board member Molly Joseph will become its next Board Chair. Cooper and Joseph will succeed John Perkins , U.S.
Imagine going in for a diagnostic MRI scan and coming out with a progressive, irreversible, and potentially fatal disease. Diagnostic and Interventional Radiology , December 2006, Vol. In a worst-case scenario, gadolinium-based contrast agents could wind up in the same unenviable position as other pharmaceuticals. "I Giles, U.K.
2] In addition to the potential benefits of these AI models in clinical use, with roughly 5,000 immunotherapies in development today [3] , selecting patients more likely to respond could also help drug developers to speed up and increase the likelihood of success of clinical trials.
Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceuticaldiagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.
announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceuticaldiagnostics, and digital portfolio. link] ii bkFusion is not available in all countries. Ask your local representative about your options. iii Immerzeel J.,
We are delighted by our collaboration with Ratio Therapeutics in advancing the clinical development of RTX-1363S as a FAP-targeted diagnostic to the clinic," stated Etienne Montagut, Lantheus' Chief Business Officer. "By milla1cf Tue, 07/11/2023 - 09:02 July 11, 2023 — Ratio Therapeutics Inc.
The results also follow those of the PICTURE clinical trial published in Investigative Radiology in May, 2023, which found the non-inferior quality of morphologic assessment of lesions of the brain and spine with VUEWAY compared with Gadavist. mmol/kg versus a full dose of gadobutrol (0.1 mmol/kg). [i] mmol/kg gadopiclenol (VUEWAY) with 0.1
The rise of precision medicine is putting new pressures on diagnostic laboratories to tap into their pathology data, as whole slide images are among the best representations of disease. The same spatial mapping will also enable Nucleai’s applications to serve as companion diagnostics that match patients to the most effective treatment.
This is a significant milestone for the clinical trial that will help determine whether contrast-enhanced mammography (CEM) improves breast cancer detection and reduces false-positive exams in women with dense breasts. For more information: www.acr.org References: 1] Breastcancer.org.
Dr. Guy Lloyd , a cardiologist and specialist in diagnostic imaging who participated in the study, highlights the importance of healthcare leaders preparing for the changes of tomorrow, “AI is going to fundamentally change the way people work,” he predicts.
PMID: 34697777 Clinical Question: In patients with moderate to severe alcohol withdrawal being discharged from the emergency department (ED), does treatment with phenobarbital alone and phenobarbital plus benzodiazepines compared to benzodiazepines alone decrease the odds of returning to the ED within 3 days after initial discharge?
Curadh), a global MTR-focused clinical, research and advisory organization, today announced a long-term strategic collaboration to develop and produce novel radiopharmaceuticals for the diagnosis and treatment of solid tumor cancers.
2, Proscia launched Concentriq Embeddings and the Proscia AI Toolkit, enabling life sciences organizations to accelerate the discovery and development of novel therapies and diagnostics. In a production setting, pharmaceutical companies can reduce AI development time from weeks to hours—allowing therapies to reach patients much sooner.
christine.book Thu, 09/07/2023 - 12:19 September 7, 2023 — Paige , a provider of end-to-end digital pathology solutions and clinical AI, has announced a collaboration with Microsoft to build what they refer to as the world’s largest image-based AI models for digital pathology and oncology.
Government hospitals face unique challenges that restrict the quality of healthcare provided thus, people prefer private hospitals and clinics. Also, the new online pharmaceutical retail industry is gradually penetrating the market. Crisil notes, the insurance coverage of Rs.
Younger patients ( Clinical symptoms can be caused directly by the tumor from obstruction or in form of embolization. Echocardiography (Transesophageal > Transthoracic) is the diagnostic test of choice followed by cardiac MRI and CT scans to help better visualize the intracardiac mass for preoperative planning [2,3]. Dtsch Arztebl Int.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content